Stock comparison
Side-by-side financials for CUE and ABBV. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
Market cap data is available for the leading company in this comparison.
Market value leader
ABBV
Latest market capitalization comparison.
Revenue leader
ABBV
CUE: $27.47M vs ABBV: $61.16B.
Profit leader
ABBV
CUE: -$26.60M vs ABBV: $4.23B.
Margin leader
ABBV
CUE: -96.9% vs ABBV: 6.9% net margin.
| Metric | CUE | ABBV |
|---|---|---|
| Market cap | - | $438.31 B |
| US-listed rank | - | #26 |
| Revenue (latest FY) | $27.47M | $61.16B |
| Net income (latest FY) | -$26.60M | $4.23B |
| Net margin | -96.9% | 6.9% |
| P/E (trailing FY) | - | 103.7x |
| SEC filings | 496 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, Cue Biopharma, Inc. reported $27.47M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Cue Biopharma, Inc. and AbbVie Inc., or browse the full rankings.